Project Grant K99HG013547
Award Date
8/6/24
Completion Date
7/31/26
Dollars Obligated
$152K
Federal Agency
National Human Genome Research Institute
Federal Grant Program
93.172
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This Project Grant award from the National Human Genome Research Institute (NHGRI), under the Human Genome Research program (CFDA 93.172), aims to develop new methods to predict disease risk among individuals with rare monogenic risk alleles. The $1,100,866 award will fund research at the Icahn School of Medicine at Mount Sinai to leverage deep learning techniques on Electronic Health Records, metabolomics, and proteomics data from sources like the UK Biobank and NIH All of Us program. The...
This federal Project Grant award of $423,750.00 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research by New York University School of Medicine to deepen understanding of the genetic basis of complex human traits and diseases. The key objectives are to: 1) identify the most important genes contributing to complex traits, 2) characterize gene-gene and gene-environment interactions, and 3) develop...
This Project Grant award, valued at $491,366, was issued by the National Human Genome Research Institute (NHGRI) under the Human Genome Research federal grant program (CFDA 93.172). The award is focused on developing new algorithms to robustly map disease-associated genetic variants to critical target genes, particularly in underrepresented populations. Key objectives include: Improving the ability to identify disease-critical genes in non-European populations where data is limited. Developing...
This $993,446 Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) will support the development of statistical and machine learning approaches to decode the regulatory activity underlying disease variants, link variants to genes in relevant cell types, and identify disease-critical co-operative programs of genes and genomic elements. The key objectives are to: 1) leverage single-cell multi-omics data to improve strategies for linking...
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) aims to develop novel statistical models for multi-trait analysis in large-scale biobank datasets linked to electronic health records. The $122,234 award, effective from September 20, 2024 to August 31, 2026, will support research at Columbia University's Health Sciences Division to enhance disease association mapping and risk prediction accuracy. Specifically, the project will: 1)...
This Project Grant award from the National Human Genome Research Institute (NHGRI), under the federal Human Genome Research grant program (CFDA 93.172), is focused on enhancing the interpretability and applicability of polygenic scores through the integration of multi-omics data and family-based studies. The primary objectives are to: 1) develop machine learning approaches to integrate genetic, multi-omics, and environmental data to construct partitioned polygenic scores representing distinct...
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) is focused on developing and applying machine learning-based approaches to estimate disease risk in diverse and admixed populations. The $399,156 award to Galatea Bio Inc., a minority-owned small disadvantaged business located in Miami Lakes, FL, will support the following key objectives over the project period from September 2024 to August 2025: Evaluating the performance of existing...
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) provides $716,587 to Boston Children's Hospital to advance equity in rare disease genomic research. The key objectives are to: Develop and implement a Diversity, Equity, and Inclusion toolkit within the Broad Institute's Rare Genomes Project to improve engagement and participation from historically underrepresented populations in rare disease genomic studies. This will involve...
The National Human Genome Research Institute (NHGRI) awarded a $1,341,011 Project Grant (CFDA 93.172 - Human Genome Research) to the University of Pittsburgh to develop a novel computational framework integrating deep learning and causal discovery algorithms. The goal is to unveil individualized cell-cell communication networks underlying tissue environment heterogeneity. The framework will model causal relationships between cells to identify ligand-receptor signal transduction pathways that...
This $1,038,898.88 Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) aims to develop novel approaches for integrating single-cell data with genome-wide association studies (GWAS) to elucidate the genetic architecture of complex diseases. The key objectives are to: 1) leverage single-cell epigenetic data to identify heritable disease components; 2) use single-cell data to fine-map disease variants and their mechanisms; and 3) define the...